Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
emtricitabine (emtriva) (1 trial)
isoniazid (nydrazid) (1 trial)
lamivudine (epivir) (2 trials)
nevirapine (viramune) (1 trial)
platelet-rich plasma (2 trials)
rifapentine (priftin) (1 trial)
stavudine (zerit) (1 trial)
tenofovir (viread) (1 trial)
zidovudine (retrovir) (2 trials)
letrozole (femara) (1 trial)
misoprostol (cytotec) (1 trial)
triamcinolone (kenalog) (1 trial)
Communicable Diseases (Phase 3)
HIV Infections (Phase 3)
Infections (Phase 3)
Latent Tuberculosis (Phase 3)
Tuberculosis (Phase 3)
Trials (7 total)
Trial APIs (12 total)